Androgen receptor axis‑targeted agents are not superior to conventional hormonal therapy for treatment of metastatic prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Androgen receptor axis‑targeted agents are not superior to conventional hormonal therapy for treatment of metastatic prostate cancer

Published:2022-08-09 Issue:4 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Wada Akinori¹,Narita Mitsuhiro¹,Nagasawa Masayuki¹,Kusaba Takuto¹,Kubota Shigehisa¹,Yoshida Tetsuya¹,Johnin Kazuyoshi¹,Kawauchi Akihiro¹,Kageyama Susumu¹

Affiliation:

1. Department of Urology, Shiga University of Medical Science, Otsu, Shiga 520‑2192, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference27 articles.

1. Enzalutamide in metastatic prostate cancer before chemotherapy;Beer;N Engl J Med,2014

2. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012

3. Abiraterone in metastatic prostate cancer without previous chemotherapy;Ryan;N Engl J Med,2013

4. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

5. ARCHES: A randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men with metastatic hormone-sensitive prostate cancer;Armstrong;J Clin Oncol,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP